Dr Amber Marie Green, PHARMD | |
105 S State St, Athens, WV 24712-1237 | |
(304) 384-7851 | |
(304) 384-4247 |
Full Name | Dr Amber Marie Green |
---|---|
Gender | Female |
Speciality | Pharmacist |
Location | 105 S State St, Athens, West Virginia |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1821602830 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | RP0008796 (West Virginia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Amber Marie Green, PHARMD 136 Landsend Ct, Princeton, WV 24739-7769 Ph: (304) 910-9633 | Dr Amber Marie Green, PHARMD 105 S State St, Athens, WV 24712-1237 Ph: (304) 384-7851 |
News Archive
The American Urological Association Foundation joins the AUA in its response to the American Cancer Society updated prostate cancer screening guidelines highlighting the importance of shared decision-making between patients and physicians.
After years in the making, U.N. Women, the U.N.'s new agency devoted to gender equality and women's empowerment, officially got to work this month. The Kaiser Daily Global Health Policy Report's Jennifer Evans spoke with Letty Chiwara, head of U.N. Women's Africa Division, to discuss the agency's launch and the overlap between issues relating to women's health and their equality and empowerment.
A new Canadian study suggests that individuals who take anti-depressants and/or anti-psychotics and participate in a weight management program can lose weight whether or not they take psychiatric medications, according to a report published online today in Obesity, the flagship journal of The Obesity Society.
The U.S. Food and Drug Administration (FDA) has approved BOOSTRIX for use in adults 65 years of age and older for active booster immunization against tetanus, diphtheria and pertussis.
"The first test of a long-acting vaginal ring loaded with an HIV-preventing drug has begun enrolling women in southern Africa," the Washington Post reports. The study, according to the newspaper, marks the 15th trial led by the nonprofit group, International Partnership for Microbicides, which "has helped lead the search for a discreet, woman-controlled means of protection" against the virus.
› Verified 8 days ago